| Age |
Traits |
Female |
Male |
| 9 weeks |
*PCV (%) |
29.00 ± 4.00b |
33.12 ± 2.73a |
|
|
*WBC |
28.90 ± 4.60a |
24.83 ± 3.15b |
|
|
*NEU (%) |
12.50 ± 1.50a |
31.00 ± 3.37b |
|
|
*LYM (%) |
87.00 ± 1.00a |
68.63 ± 3.43b |
|
|
EOS (%) |
0.00 ± 0.00 |
0.38 ± 0.18 |
|
|
MON (%) |
0.50 ± 0.50 |
0.00 ± 0.00 |
| 17 weeks |
|
|
|
|
|
PCV (%) |
42.50 ± 1.50 |
41.75 ± 0.45 |
|
|
WBC (×103/µl) |
36.10 ± 4.20 |
32.18 ± 1.92 |
|
|
NEU (%) |
30.00 ± 6.00 |
32.38 ± 3.56 |
|
|
LYM (%) |
63.00 ± 5.00 |
63.12 ± 3.61 |
|
|
EOS (%) |
2.50 ± 2.50 |
1.75 ± 1.03 |
|
|
MON (%) |
4.50 ± 1.50 |
2.75 ± 0.65 |
| 25 weeks |
|
|
|
|
|
*PCV (%) |
42.00 ± 0.00a |
38.33 ± 1.38b |
|
|
*WBC (×103/µl) |
41.00 ± 0.00a |
34.63 ± 1.94b |
|
|
*NEU (%) |
22.00 ± 0.00b |
34.17 ± 2.66a |
|
|
*LYM (%) |
72.00 ± 0.00a |
59.17 ± 2.17b |
|
|
*EOS (%) |
3.00 ± 0.00b |
4.83 ± 0.65a |
|
|
*MON (%) |
3.00 ± 0.00b |
5.17 ± 0.40a |